Discovering therapies that do not cause resistance, one of the challenges of cancer research

Angel R. Nebreda, head of the Signalling and Cell Cycle Laboratory at IRB Barcelona

Angel R. Nebreda, head of the Signalling and Cell Cycle Laboratory at IRB Barcelona


La Opinión de Zamora has published an article summarising the days of oncological research organised by the United Association against Cancer Toro and its Alfoz (AUCCTA) and in which Angel R. Nebreda, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) participated. During his talk, Nebreda commented: "We have come a long way but we still have a lot to do.But think about what we have achieved in the last 30 years, we know a lot more about how cancer develops and we have many more diagnostic methods, we know that there are hereditary cancers, that are genetic, and that they can be prevented by removing breasts and ovaries. We know that lung cancer is directly caused by smoking, and we have advanced in therapies. Some of these work very well, although the problem is resistance".

Link to La Opinión de Zamora